- Home
- ZBIO vs GELS Comparison
ZBIO vs GELS Comparison
Compare ZBIO & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- GELS
- Stock Information
- Founded
- ZBIO 2019
- GELS 2018
- Country
- ZBIO United States
- GELS Australia
- Employees
- ZBIO N/A
- GELS N/A
- Industry
- ZBIO
- GELS
- Sector
- ZBIO
- GELS
- Exchange
- ZBIO NYSE
- GELS NYSE
- Market Cap
- ZBIO 389.2M
- GELS 15.9M
- IPO Year
- ZBIO 2024
- GELS 2024
- Fundamental
- Price
- ZBIO $11.18
- GELS $1.81
- Analyst Decision
- ZBIO Strong Buy
- GELS
- Analyst Count
- ZBIO 7
- GELS 0
- Target Price
- ZBIO $32.29
- GELS N/A
- AVG Volume (30 Days)
- ZBIO 175.9K
- GELS 232.4K
- Earning Date
- ZBIO 08-16-2025
- GELS 02-15-2025
- Dividend Yield
- ZBIO N/A
- GELS N/A
- EPS Growth
- ZBIO N/A
- GELS N/A
- EPS
- ZBIO N/A
- GELS N/A
- Revenue
- ZBIO $15,000,000.00
- GELS $233,830.00
- Revenue This Year
- ZBIO $206.00
- GELS N/A
- Revenue Next Year
- ZBIO $41.92
- GELS N/A
- P/E Ratio
- ZBIO N/A
- GELS N/A
- Revenue Growth
- ZBIO N/A
- GELS 10.19
- 52 Week Low
- ZBIO $5.83
- GELS $0.77
- 52 Week High
- ZBIO $26.25
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- GELS N/A
- Support Level
- ZBIO N/A
- GELS N/A
- Resistance Level
- ZBIO N/A
- GELS N/A
- Average True Range (ATR)
- ZBIO 0.00
- GELS 0.00
- MACD
- ZBIO 0.00
- GELS 0.00
- Stochastic Oscillator
- ZBIO 0.00
- GELS 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.